Rhythm Pharmaceuticals GAAP EPS of -$0.61 beats by $0.10, revenue of $92.1M beats by $7.5M

See Rhythm Pharmaceuticals' Q3 earnings: EPS beat estimates, revenue surged 79.5% year over year, and shares fell premarket.